Newsfeeds Archive - Page 124 of 130

1 minute read

CNBC’s Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company

August 18, 8:10 AM

On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Easterly Government Properties Inc (NYSE: DEA) offers a 5.6% yield.

AMGN

1 minute read

Why This JM Smucker Analyst Is Turning Bullish ‘As Consumer Wallets Tighten’

By Priya Nigam

August 17, 4:21 PM

Shares of JM Smucker Co (NYSE: SJM) have lagged the packaged food peers year-to-date, and this gap is likely to close as the company executes on its fiscal 2023 outlook, according to BofA Securities.

SJM

2 minute read

3 Home Depot Analysts On Retailer’s Q2 Earnings Beat: ‘Longer-Term Outlook Remains Favorable’

By Priya Nigam

August 17, 1:45 PM

Home Depot Inc (NYSE: HD) reported quarterly earnings and revenues ahead of Street expectations Tuesday and reiterated its 2022 guidance. Raymond James On Home Depot

1 minute read

Apple’s New iPhone Is On The Way: Wedbush Revises Price Target, Examines Supply Chain

By Priya Nigam

August 17, 12:27 PM

Apple Inc. (NASDAQ: AAPL) will launch the iPhone 14 in mid-September and seems to be in a strong position from a supply perspective, according to Wedbush.

AAPL

1 minute read

Traders Anticipating Big Rally Ahead For Bed Bath & Beyond

By Priya Nigam

August 17, 8:37 AM

On CNBC's "Options Action," Michael Khouw of Optimize Advisors said that Bed Bath & Beyond Inc (NASDAQ: BBBY) traded 7.8 times its average daily volume on Tuesday.

BBBY

1 minute read

CNBC’s Final Trades: Aptiv, CrowdStrike, Goldman Sachs And This Media Conglomerate

By Priya Nigam

August 17, 8:30 AM

On CNBC’s “Halftime Report Final Trades,” Stephanie Link of Hightower said that she likes Aptiv PLC (NYSE: APTV) “a lot.” “Down 34%, they’ve

APTV

1 minute read

Seagen For Sale? This Acquisition Target Is ‘Too Intriguing To Ignore,’ RBC Says

By Priya Nigam

August 16, 11:03 AM

The recent pressure on Seagen Inc.’s (NASDAQ: SGEN) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.”

MRK